Dr. Liu on Navigating the Frontline Treatment of ALK+ NSCLC OncLive 1:22 6 years ago 84 Далее Скачать
Dr. Xia on the Frontline Treatment Landscape of ALK-Positive NSCLC OncLive 1:17 5 years ago 242 Далее Скачать
Dr. Liu on Potentially Promising Combinations in ALK-Positive NSCLC OncLive 1:41 6 years ago 216 Далее Скачать
Management of frontline ALK+ NSCLC: brigatinib vs. alectinib VJOncology 3:04 4 years ago 1 238 Далее Скачать
Dr. Camidge Discusses Treatment of Patients With ALK+ NSCLC OncLive 1:51 5 years ago 534 Далее Скачать
Dr. Velcheti on Potential of Alectinib in Frontline ALK-Positive NSCLC OncLive 1:42 8 years ago 223 Далее Скачать
Dr. Stephen Liu joins ALKtALK on June 30, 2024 ALK Positive Inc. 1:03:35 5 months ago 1 838 Далее Скачать
Dr. West on FDA Approval of Frontline Alectinib in ALK+ NSCLC OncLive 0:55 7 years ago 124 Далее Скачать
ALK-positive NSCLC: the role of treatment selection and sequencing VJOncology 3:34 6 years ago 380 Далее Скачать
Dr. Kelly Discusses the Treatment of Patients With ALK+ NSCLC OncLive 1:53 5 years ago 192 Далее Скачать
NAUTIKA1: safety and tolerability of neoadjuvant alectinib in ALK-positive NSCLC VJOncology 0:56 2 years ago 527 Далее Скачать
Exploring Treatment Options for Patients with ALK-Mutated Lung Cancer Targeted Oncology 0:58 4 years ago 280 Далее Скачать
